S

Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581

Watchlist Manager
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Watchlist
Price: 13.51 CNY 4.24% Market Closed
Market Cap: 8.9B CNY
Have any thoughts about
Shandong Sinobioway Biomedicine Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Shandong Sinobioway Biomedicine Co Ltd

Current Assets 742.3m
Cash & Short-Term Investments 434.4m
Receivables 225.1m
Other Current Assets 82.8m
Non-Current Assets 1.5B
Long-Term Investments 1.1B
PP&E 314.9m
Intangibles 104.4m
Other Non-Current Assets 19.5m
Current Liabilities 86.2m
Accounts Payable 35.1m
Accrued Liabilities 8.2m
Short-Term Debt 10m
Other Current Liabilities 32.9m
Non-Current Liabilities 139.9m
Long-Term Debt 320.4k
Other Non-Current Liabilities 139.6m

Balance Sheet
Shandong Sinobioway Biomedicine Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
371
874
769
1 816
1 546
1 121
284
188
144
152
Cash
0
0
0
0
0
1
1
188
144
152
Cash Equivalents
371
873
769
1 816
1 545
1 120
283
0
0
0
Total Receivables
223
476
674
821
1 098
575
396
295
208
254
Accounts Receivables
158
304
419
472
442
438
320
252
167
134
Other Receivables
65
172
255
349
655
137
77
43
41
120
Inventory
49
62
64
60
55
67
71
64
80
85
Other Current Assets
2
8
8
4
156
39
15
22
88
6
Total Current Assets
645
1 420
1 515
2 702
2 855
1 801
766
568
518
497
PP&E Net
324
480
486
506
830
797
745
797
706
358
PP&E Gross
324
480
486
506
830
797
745
797
706
358
Accumulated Depreciation
246
349
398
441
480
524
446
494
548
869
Intangible Assets
56
99
94
115
115
157
145
134
126
108
Goodwill
0
193
193
183
20
20
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
11
Long-Term Investments
199
213
353
453
435
581
751
1 223
1 503
1 355
Other Long-Term Assets
40
12
46
40
52
57
38
33
17
8
Other Assets
0
193
193
183
20
20
0
0
0
0
Total Assets
1 264
N/A
2 416
+91%
2 688
+11%
3 998
+49%
4 307
+8%
3 414
-21%
2 445
-28%
2 756
+13%
2 870
+4%
2 337
-19%
Liabilities
Accounts Payable
20
28
35
26
33
30
15
42
44
74
Accrued Liabilities
23
38
47
56
50
35
29
27
27
17
Short-Term Debt
202
109
6
111
451
156
127
157
154
17
Current Portion of Long-Term Debt
21
4
1
1
0
0
21
16
13
0
Other Current Liabilities
59
57
40
63
32
18
15
17
126
26
Total Current Liabilities
325
235
128
257
566
240
207
259
364
134
Long-Term Debt
5
1
1
791
880
764
28
10
1
1
Deferred Income Tax
16
17
14
16
14
10
9
9
8
8
Minority Interest
69
59
58
62
74
77
73
81
95
105
Other Liabilities
16
19
17
15
13
12
11
10
16
22
Total Liabilities
431
N/A
331
-23%
218
-34%
1 141
+423%
1 548
+36%
1 102
-29%
328
-70%
368
+12%
485
+32%
269
-45%
Equity
Common Stock
131
229
229
229
229
229
229
229
229
229
Retained Earnings
251
501
886
1 274
1 168
1 226
1 030
1 301
1 298
965
Additional Paid In Capital
451
1 355
1 355
1 355
1 362
857
858
858
859
874
Total Equity
833
N/A
2 085
+150%
2 470
+18%
2 858
+16%
2 759
-3%
2 312
-16%
2 117
-8%
2 388
+13%
2 385
0%
2 068
-13%
Total Liabilities & Equity
1 264
N/A
2 416
+91%
2 688
+11%
3 998
+49%
4 307
+8%
3 414
-21%
2 445
-28%
2 756
+13%
2 870
+4%
2 337
-19%
Shares Outstanding
Common Shares Outstanding
282
660
660
660
660
660
660
660
660
660

See Also

Discover More